05.01.2023 16:35 | HEMO | Price Monitoring Extension | RNS |
05.01.2023 11:05 | HEMO | Second Price Monitoring Extn | RNS |
05.01.2023 11:00 | HEMO | Price Monitoring Extension | RNS |
04.01.2023 11:12 | HEMO | IN BRIEF: Hemogenyx Pharma second process qualification run successful | Alliance |
04.01.2023 10:36 | HEMO, HEIQ | SMALL-CAP WINNERS & LOSERS: HeiQ drops on expectation of lower sales | Alliance |
04.01.2023 07:00 | HEMO | HEMO-CAR-T Process Qualification Run Completed | Reach |
12.12.2022 07:00 | HEMO | HEMO-CAR-T First PQ Run Completed | Reach |
18.11.2022 16:21 | HEMO | Hemogenyx makes final development run of HEMO-CAR-T cell manufacture | Alliance |
18.11.2022 15:19 | HEMO | HEMO-CAR-T Process Development Runs Completed | Reach |
18.11.2022 11:05 | HEMO | Second Price Monitoring Extn | RNS |
18.11.2022 11:00 | HEMO | Price Monitoring Extension | RNS |
27.10.2022 16:40 | HEMO | Second Price Monitoring Extn | RNS |
27.10.2022 16:35 | HEMO | Price Monitoring Extension | RNS |
27.10.2022 14:05 | HEMO | Second Price Monitoring Extn | RNS |
27.10.2022 14:00 | HEMO | Price Monitoring Extension | RNS |
29.09.2022 15:09 | TRAF, HEMO | EARNINGS UPDATES: Hemogenyx hopes on cancer drug; IDE loss widens | Alliance |
29.09.2022 08:00 | HEMO | Half-year Report | RNS |
01.09.2022 08:45 | HEMO | Presentation at H.C. Wainwright Global Conference | Reach |
22.08.2022 07:00 | HEMO | Appointment of Director of Quality | RNS |
15.08.2022 09:50 | HEMO | Hemogenyx wins patent for bi-specific antibody method in China | Alliance |
15.08.2022 07:00 | HEMO | Approval and Issuance of Antibody Patent | RNS |
10.08.2022 13:44 | HEMO | Hemogenyx Pharmaceuticals names Koen van Besien as medical director | Alliance |
10.08.2022 07:00 | HEMO | Appointment of Medical Director | RNS |
09.08.2022 14:06 | HEMO | Second Price Monitoring Extn | RNS |
09.08.2022 14:00 | HEMO | Price Monitoring Extension | RNS |
13.07.2022 15:36 | HEMO | IN BRIEF: Hemogenyx Pharma opens new lab to manufacture cells in-house | Alliance |
13.07.2022 07:00 | HEMO | New Custom R&D Facility Opening | RNS |
08.07.2022 12:25 | HEMO | Investor Webinar Recording | Reach |
01.07.2022 12:19 | HEMO | Change of Registered Office | RNS |
30.06.2022 15:29 | HEMO | Result of Annual General Meeting | RNS |
27.06.2022 07:00 | HEMO | Investor Webinar | Reach |
23.06.2022 16:02 | VAL, TRN, TRP | UK shareholder meetings calendar - next 7 days | Alliance |
07.06.2022 14:17 | HEMO | Posting of Annual Report & Notice of AGM | RNS |
30.05.2022 07:00 | HEMO | Director/PDMR Shareholding | RNS |
27.05.2022 14:05 | HEMO | Second Price Monitoring Extn | RNS |
27.05.2022 14:00 | HEMO | Price Monitoring Extension | RNS |
16.05.2022 07:00 | HEMO | Immuno-Oncology Summit Europe Presentation | Reach |
29.04.2022 19:34 | GCAT, OMI, SIGC | TRADING UPDATES: Aurora Investment Trust beats annual benchmark | Alliance |
29.04.2022 17:39 | HEMO | Final Results for the Year Ended 31 December 2021 | RNS |
21.03.2022 16:42 | HEMO | Second Price Monitoring Extn | RNS |
21.03.2022 16:36 | HEMO | Price Monitoring Extension | RNS |
21.03.2022 14:06 | HEMO | Second Price Monitoring Extn | RNS |
21.03.2022 14:01 | HEMO | Price Monitoring Extension | RNS |
16.03.2022 07:00 | HEMO | CBR Update | RNS |
04.03.2022 14:05 | HEMO | Second Price Monitoring Extn | RNS |
04.03.2022 14:00 | HEMO | Price Monitoring Extension | RNS |
04.03.2022 11:05 | HEMO | Second Price Monitoring Extn | RNS |
04.03.2022 11:00 | HEMO | Price Monitoring Extension | RNS |
16.02.2022 07:00 | HEMO | HEMO-CAR-T pre-IND Meeting Request | Reach |
12.01.2022 07:00 | HEMO | Hemogenyx Pharmaceuticals Partnership with Selexis | RNS |
05.01.2022 07:00 | HEMO | H.C. Wainwright Bioconnect Conference | Reach |
22.12.2021 14:05 | HEMO | Second Price Monitoring Extn | RNS |
22.12.2021 14:00 | HEMO | Price Monitoring Extension | RNS |
22.12.2021 11:06 | HEMO | Second Price Monitoring Extn | RNS |
22.12.2021 11:01 | HEMO | Price Monitoring Extension | RNS |
20.12.2021 07:00 | HEMO | Hemo-CAR-T partnership with WuXi ATU | RNS |
13.12.2021 09:00 | HEMO | Price Monitoring Extension | RNS |
13.12.2021 08:55 | HEMO | HEMO-CAR-T pre-IND Meeting Request | RNS |
24.11.2021 14:38 | HEMO | Convertible Loans Repayment | RNS |
18.10.2021 07:00 | HEMO | Lease of New York Mink Building Custom Laboratory | Reach |
13.10.2021 08:30 | HEMO | CDX Licence Agreement | RNS |
12.10.2021 16:41 | HEMO | Second Price Monitoring Extn | RNS |
12.10.2021 16:36 | HEMO | Price Monitoring Extension | RNS |
30.09.2021 08:00 | HEMO | Half-year Report | RNS |
02.09.2021 07:00 | HEMO | U.S. Approval of Monoclonal Antibody Patent | RNS |
26.07.2021 07:00 | HEMO | Appointment of Business Advisor & Board Observer | RNS |
02.07.2021 11:23 | HEMO | Corporate Presentation | Reach |
25.06.2021 15:32 | HEMO | Result of Annual General Meeting | RNS |
16.06.2021 16:40 | HEMO | Second Price Monitoring Extn | RNS |
16.06.2021 16:35 | HEMO | Price Monitoring Extension | RNS |
15.06.2021 12:41 | HEMO | Changes to 2021 AGM Arrangements | RNS |
15.06.2021 11:06 | HEMO | Second Price Monitoring Extn | RNS |
15.06.2021 11:00 | HEMO | Price Monitoring Extension | RNS |
02.06.2021 16:11 | HEMO | U.S. Approval and Issuance of CDX Antibody Patent | RNS |
28.05.2021 14:00 | HEMO | Posting of Annual Report & Notice of AGM | RNS |